BATS BZX Real-Time Price
As of 11:51am ET
| +0.46 / +0.72%|
The 19 analysts offering 12-month price forecasts for ResMed Inc have a median target of 71.06, with a high estimate of 78.46 and a low estimate of 50.00. The median estimate represents a +10.65% increase from the last price of 64.22.
The current consensus among 23 polled investment analysts is to Buy stock in ResMed Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.